Israeli startup, Scopio Labs, announced that it has completed a $15 million funding round, led by Olive Tree Ventures, for the purpose of developing its digital microscope system for clinical trials and research.

Like A Lab On The Go

Scopio is developing a digital microscope that can increase 100 times the size and is able to scan different surfaces onto a diagnostics network. So, for example, medical service providers can enjoy fast diagnostics capabilities, as if the lab were right next to them. In addition to the device itself, the system also assists different factors in the testing and diagnostic systems in order to make calculated decisions based on machine learning insight. The system is currently in use at various medical centers, veterinarian practices, university research labs, and in the global pharmacology industry. Recently, the company was officially granted the regulatory European CE standard.

The company was founded in 2015 by Ithai Hayut and Erez Na’aman. The company’s recent funding round was led by Olive Tree Ventures, in cooperation with LR Group, OurCrowd, Aurum Ventures, as well as other investors.

Ithai Hayut, the CEO, said in response to the funding series: “We are delighted to add further investors that support our vision and efforts to promote the clinical and research industries, while also integrating the microscope into new areas - industries that have not yet joined the digital revolution - because of the complexity of high-resolution scanning.”